Searched for
BULK DRUGS
Drug formulations & biologicals keep India's pharma exports healthy in Q1During the first quarter of fiscal 2027, India's pharmaceutical exports soared to $8.10 billion, showcasing remarkable strength in drug for...- Nutraceuticals, get it right from the startThe Indian supplements market is anticipated to soar to nearly fifty-seven billion dollars by twenty thirty, driven by heightened consumer ...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of more than 23%Market breadth (always a better indicator of the underlying sentiment) has remained positive for a few trading sessions in a row. This is w...
- Govt weighs PLI 2.0 with sharper focus on high-performing sectorsIndia is planning a second phase for its production-linked incentive programme. This new phase will support high-performing sectors and red...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of more than 20%It was after quite some time that market breadth, always a better indicator of underlying sentiment, was positive for a few trading session...
- The ethanol story is changing. Is investing in the ecosystem the better way? 15 stocks across different market cap segmentsThe ethanol story started simply enough: Cut India's dependence on imported crude oil. It would save foreign exchange. Give farmers a new a...
- Parliament watch: FTA exports rise, PLI payouts growIndia's merchandise exports to its free trade agreement (FTA) partner countries rose 25% year-on-year to $43.14 billion in the April-June q...
- Govt disburses Rs 35,354 crore as on March 31 under PLI schemes: Jitin PrasadaProduction Linked Incentive schemes, which aim to boost manufacturing and attract significant investments, have disbursed Rs 35,354 crore t...
- Inside Iran's accelerating execution campaign amid wartime crackdownIran has executed dozens of political prisoners since the war began. Activists fear intensified executions to instill societal fear and sil...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsAfter four days of relative outperformance, the Indian market is seemingly in trouble: Both the indices (the Nifty and Sensex) and market b...
- Pharma exports to UK may rise up to 10% in FY27 as CETA takes effectIndia's pharmaceutical exports to the UK are set to witness substantial growth thanks to the recently negotiated Comprehensive Economic and...
- India-UK FTA projected to boost Indian pharma exports by over 8% to $981 million in FY27: PharmexcilIndian pharmaceutical exports to the United Kingdom are projected to grow significantly. The India-UK Comprehensive Economic and Trade Agre...
- Ethanol ecosystem: Judging fear by noise is not evidence; 15 stocks from the ecosystemSugar is one of the oldest distressed sectors in India. For decades it has swung between glut and shortage, carried heavy debt, was depende...
- Pharma body renews push for data protectionLeading pharmaceutical companies seek Regulatory Data Protection to boost research investments. Public health groups and local makers oppos...
- India-UK FTA: Pharma industry flags regulatory priorities ahead of July 15 rolloutIndustry stakeholders expect stronger trade, investment, and research partnerships but say implementation clarity will determine the pact’s...
- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsOver the next few trading sessions, the direction of indices like the Nifty and Sensex will be determined by news on ceasefire violations a...
- Modi govt hurt national interests by letting China capture India's critical industries: CongressCongress president Mallikarjun Kharge accused the government of harming national interests. He cited reports claiming China powers India's ...
- India proposes dedicated BRICS Virtual Working Group to combat drug traffickingIn a proactive move, India has suggested establishing a dedicated virtual working group within BRICS to address the increasingly sophistica...
- US, West Asia drag India's pharma exports growthIndian pharmaceutical exports to the US, its largest market, saw a dip in early fiscal months, alongside a slight decline in shipments to W...
- New rules simplify drug launches, reduce manufacturer liability for overchargingNew rules now allow drug manufacturers to launch similar medicines without prior price approval, streamlining market entry. Companies can s...
Load More
